Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Duffy, MJ
   Clinical uses of tumor markers: A critical review
   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
   
   M.J. Duffy, "Clinical uses of tumor markers: A critical review", CR R CL LAB, 38(3), 2001, pp. 225-262
2. Gaci, Z; Bouin-Pineau, MH; Gaci, M; Daban, A; Ingrand, P; Metaye, T
   Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup ofnode-negative breast cancer patients with low histological grade tumors
   INTERNATIONAL JOURNAL OF ONCOLOGY
   
   Z. Gaci et al., "Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup ofnode-negative breast cancer patients with low histological grade tumors", INT J ONCOL, 18(4), 2001, pp. 793-800
3. Chen, Y; Emtage, P; Zhu, Q; Foley, R; Muller, W; Hitt, M; Gauldie, J; Wan, Y
   Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12
   GENE THERAPY
   
   Y. Chen et al., "Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12", GENE THER, 8(4), 2001, pp. 316-323
4. Carpenter, R
   Sentinel node biopsy should be introduced into routine practice before results of randomized trials are available
   BREAST
   
   R. Carpenter, "Sentinel node biopsy should be introduced into routine practice before results of randomized trials are available", BREAST, 10(4), 2001, pp. 281-284
5. Cooke, T; Reeves, J; Lannigan, A; Stanton, P
   The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker
   EUROPEAN JOURNAL OF CANCER
   
   T. Cooke et al., "The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker", EUR J CANC, 37, 2001, pp. S3-S10
6. van de Vijver, MJ
   Assessment of the need and appropriate method for testing for the human epidermal growth factor receptor-2 (HER2)
   EUROPEAN JOURNAL OF CANCER
   
   M.J. van de Vijver, "Assessment of the need and appropriate method for testing for the human epidermal growth factor receptor-2 (HER2)", EUR J CANC, 37, 2001, pp. S11-S17
7. Valagussa, P
   HER2 status: A statistician's view
   ANNALS OF ONCOLOGY
   
   P. Valagussa, "HER2 status: A statistician's view", ANN ONCOL, 12, 2001, pp. 29-34
8. Yazici, H; Altun, M; Hafiz, G; Dalay, N
   Serum and tissue c-erb B2, bcl-2, and mutant p53 oncoprotein levels in nasopharyngeal cancer
   CANCER INVESTIGATION
   
   H. Yazici et al., "Serum and tissue c-erb B2, bcl-2, and mutant p53 oncoprotein levels in nasopharyngeal cancer", CANCER INV, 19(8), 2001, pp. 773-778
9. Keshtgar, MRS; Baum, M
   Axillary dissection over the years: Where to from here?
   WORLD JOURNAL OF SURGERY
   
   M.R.S. Keshtgar e M. Baum, "Axillary dissection over the years: Where to from here?", WORLD J SUR, 25(6), 2001, pp. 761-766
10. Colpaert, C; Vermeulen, P; van Beest, P; Goovaerts, G; Weyler, J; Van Dam, P; Dirix, L; Van Marck, E
    Intratumoral hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph node-negative breastcancer patients
    HISTOPATHOLOGY
    
    C. Colpaert et al., "Intratumoral hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph node-negative breastcancer patients", HISTOPATHOL, 39(4), 2001, pp. 416-425
11. Wakui, S; Muto, T; Yokoo, K; Yokoo, R; Takahashi, H; Masaoka, T; Hano, H; Furusato, M
    Prognostic status of p53 gene mutation in canine mammary carcinoma
    ANTICANCER RESEARCH
    
    S. Wakui et al., "Prognostic status of p53 gene mutation in canine mammary carcinoma", ANTICANC R, 21(1B), 2001, pp. 611-616
12. Wersto, RP; Chrest, FJ; Leary, JF; Morris, C; Stetler-Stevenson, M; Gabrielson, E
    Doublet discrimination in DNA cell-cycle analysis
    CYTOMETRY
    
    R.P. Wersto et al., "Doublet discrimination in DNA cell-cycle analysis", CYTOMETRY, 46(5), 2001, pp. 296-306
13. Kato, T; Kameoka, S; Kimura, T; Nishikawa, T; Kasajima, T
    Angiogenesis and blood vessel invasion as prognostic indicators for node-negative breast cancer
    BREAST CANCER RESEARCH AND TREATMENT
    
    T. Kato et al., "Angiogenesis and blood vessel invasion as prognostic indicators for node-negative breast cancer", BREAST CANC, 65(3), 2001, pp. 203-215
14. Daidone, MG; Costa, A; Silvestrini, R
    Cell proliferation markers in human solid tumors: Assessing their impact in clinical oncology
    METHODS IN CELL BIOLOGY, VOL 64
    
    M.G. Daidone et al., "Cell proliferation markers in human solid tumors: Assessing their impact in clinical oncology", METH CELL B, 64, 2001, pp. 359-384
15. Cvetkovic, D; Movsas, B; Dicker, AP; Hanlon, AL; Greenberg, RE; Chapman, JD; Hanks, GE; Tricoli, JV
    Increased hypoxia correlates with increased expression of the angiogenesismarker vascular endothelial growth factor in human prostate cancer
    UROLOGY
    
    D. Cvetkovic et al., "Increased hypoxia correlates with increased expression of the angiogenesismarker vascular endothelial growth factor in human prostate cancer", UROLOGY, 57(4), 2001, pp. 821-825
16. Nio, Y; Dong, M; Iguchi, C; Yamasawa, K; Toga, T; Itakura, M; Tamura, K
    Expression of Bcl-2 and p53 protein in resectable invasive ductal carcinoma of the pancreas: Effects on clinical outcome and efficacy of adjuvant chemotherapy
    JOURNAL OF SURGICAL ONCOLOGY
    
    Y. Nio et al., "Expression of Bcl-2 and p53 protein in resectable invasive ductal carcinoma of the pancreas: Effects on clinical outcome and efficacy of adjuvant chemotherapy", J SURG ONC, 76(3), 2001, pp. 188-196
17. Colpaert, C; Vermeulen, P; Jeuris, W; van Beest, P; Goovaerts, G; Weyler, J; Van Dam, P; Dirix, L; Van Marck, E
    Early distant relapse in 'node-negative' breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of theprimary tumour
    JOURNAL OF PATHOLOGY
    
    C. Colpaert et al., "Early distant relapse in 'node-negative' breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of theprimary tumour", J PATHOLOGY, 193(4), 2001, pp. 442-449
18. Jordan, VC
    Selective estrogen receptor modulation: A personal perspective
    CANCER RESEARCH
    
    V.C. Jordan, "Selective estrogen receptor modulation: A personal perspective", CANCER RES, 61(15), 2001, pp. 5683-5687
19. Coradini, D; Boracchi, P; Daidone, MG; Pellizzaro, C; Miodini, P; Ammatuna, M; Tomasic, G; Biganzoli, E
    Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer
    BRITISH JOURNAL OF CANCER
    
    D. Coradini et al., "Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer", BR J CANC, 85(6), 2001, pp. 795-797
20. Wong, SL; Edwards, MJ; Chao, C; Tuttle, TM; Noyes, RD; Woo, C; Cerrito, PB; McMasters, KM
    Predicting the status of the nonsentinel axillary nodes a - Multicenter study
    ARCHIVES OF SURGERY
    
    S.L. Wong et al., "Predicting the status of the nonsentinel axillary nodes a - Multicenter study", ARCH SURG, 136(5), 2001, pp. 563-567
21. O'Malley, FP; Parkes, R; Latta, E; Tjan, S; Zadro, T; Mueller, R; Arneson, N; Blackstein, M; Andrulis, I
    Comparison of HER2/neu status assessed by quantitative polymerase chain reaction and immunohistochemistry
    AJCP. American journal of clinical pathology
    
    F.P. O'Malley et al., "Comparison of HER2/neu status assessed by quantitative polymerase chain reaction and immunohistochemistry", AM J CLIN P, 115(4), 2001, pp. 504-511
22. Love, RR; Kurtycz, DF; Dumesic, DA; Laube, DW; Yang, TGF
    The effects of tamoxifen on the vaginal epithelium in postmenopausal women
    JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE
    
    R.R. Love et al., "The effects of tamoxifen on the vaginal epithelium in postmenopausal women", J WOMEN H G, 9(5), 2000, pp. 559-563
23. Ohmura, Y; Aoe, M; Andou, A; Shimizu, N
    Telomerase activity and Bcl-2 expression in non-small cell lung cancer
    CLINICAL CANCER RESEARCH
    
    Y. Ohmura et al., "Telomerase activity and Bcl-2 expression in non-small cell lung cancer", CLIN CANC R, 6(8), 2000, pp. 2980-2987
24. Nienaber, VL; Davidson, D; Edalji, R; Giranda, VL; Klinghofer, V; Henkin, J; Magdalinos, P; Mantei, R; Merrick, S; Severin, JM; Smith, RA; Stewart, K; Walter, K; Wang, JY; Wendt, M; Weitzberg, M; Zhao, XM; Rockway, T
    Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsite
    STRUCTURE WITH FOLDING & DESIGN
    
    V.L. Nienaber et al., "Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsite", STRUCT F D, 8(5), 2000, pp. 553-563
25. Asgeirsson, KS; Jonasson, JG; Tryggvadottir, L; Olafsdottir, K; Sigurgeirsdottir, JR; Ingvarsson, S; Ogmundsdottir, HM
    Altered expression of E-cadherin in breast cancer: patterns, mechanisms and clinical significance
    EUROPEAN JOURNAL OF CANCER
    
    K.S. Asgeirsson et al., "Altered expression of E-cadherin in breast cancer: patterns, mechanisms and clinical significance", EUR J CANC, 36(9), 2000, pp. 1098-1106
26. Meng, TC; Lee, MS; Lin, MF
    Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells
    ONCOGENE
    
    T.C. Meng et al., "Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells", ONCOGENE, 19(22), 2000, pp. 2664-2677
27. Silvestrini, R
    Relevance of DNA-ploidy as a prognostic instrument for solid tumors
    ANNALS OF ONCOLOGY
    
    R. Silvestrini, "Relevance of DNA-ploidy as a prognostic instrument for solid tumors", ANN ONCOL, 11(3), 2000, pp. 259-261
28. DiFrancesco, LM; Murthy, SK; Luider, J; Demetrick, DJ
    Laser capture microdissection-guided fluorescence in situ hybridization and flow cytometric cell cycle analysis of purified nuclei from paraffin sections
    MODERN PATHOLOGY
    
    L.M. DiFrancesco et al., "Laser capture microdissection-guided fluorescence in situ hybridization and flow cytometric cell cycle analysis of purified nuclei from paraffin sections", MOD PATHOL, 13(6), 2000, pp. 705-711
29. Rickert, D; Mittermayer, C; Lindenfelser, R; Biesterfeld, S
    MIB-1 immunohistometry of follicular adenoma and follicular carcinoma of the thyroid gland
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
    
    D. Rickert et al., "MIB-1 immunohistometry of follicular adenoma and follicular carcinoma of the thyroid gland", ANAL QUAN C, 22(3), 2000, pp. 229-234
30. Breuer, B; Anderson, R
    The relationship of tamoxifen with dementia, depression, and dependence inactivities of daily living in elderly nursing home residents
    WOMEN & HEALTH
    
    B. Breuer e R. Anderson, "The relationship of tamoxifen with dementia, depression, and dependence inactivities of daily living in elderly nursing home residents", WOMEN HEAL, 31(1), 2000, pp. 71-85
31. Bayerlein, K; Rith, T; Verdorfer, I; Liehr, T; Wolff, E; Girod, S; Gebhart, E
    I-FISH control of CGH-detected gain of DNA sequence copy number in oral squamous cell carcinomas (OSCC)
    ANTICANCER RESEARCH
    
    K. Bayerlein et al., "I-FISH control of CGH-detected gain of DNA sequence copy number in oral squamous cell carcinomas (OSCC)", ANTICANC R, 20(1A), 2000, pp. 427-432
32. Dahm-Daphi, J
    p53: Biology and role for cellular radiosensitivity
    STRAHLENTHERAPIE UND ONKOLOGIE
    
    J. Dahm-Daphi, "p53: Biology and role for cellular radiosensitivity", STRAH ONKOL, 176(6), 2000, pp. 278-285
33. Volpi, A; De Paola, F; Nanni, O; Granato, AM; Bajorko, P; Becciolini, A; Scarpi, E; Riccobon, A; Balzi, M; Amadori, D
    Prognostic significance of biologic markers in node-negative breast cancerpatients: a prospective study
    BREAST CANCER RESEARCH AND TREATMENT
    
    A. Volpi et al., "Prognostic significance of biologic markers in node-negative breast cancerpatients: a prospective study", BREAST CANC, 63(3), 2000, pp. 181-192
34. Gregory, RK; Powles, TJ; Salter, J; Chang, JC; Ashley, S; Dowsett, M
    Prognostic relavance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy
    BREAST CANCER RESEARCH AND TREATMENT
    
    R.K. Gregory et al., "Prognostic relavance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy", BREAST CANC, 59(2), 2000, pp. 171-175
35. Busse, D; Doughty, RS; Arteaga, CL
    HER-2/neu (erbB-2) and the cell cycle
    SEMINARS IN ONCOLOGY
    
    D. Busse et al., "HER-2/neu (erbB-2) and the cell cycle", SEMIN ONCOL, 27(6), 2000, pp. 3-8
36. Scholzen, T; Gerdes, J
    The Ki-67 protein: From the known and the unknown
    JOURNAL OF CELLULAR PHYSIOLOGY
    
    T. Scholzen e J. Gerdes, "The Ki-67 protein: From the known and the unknown", J CELL PHYS, 182(3), 2000, pp. 311-322
37. Earle, CC; Venditti, LN; Neumann, PJ; Gelber, RD; Weinstein, MC; Potosky, AL; Weeks, JC
    Who gets chemotherapy for metastatic lung cancer?
    CHEST
    
    C.C. Earle et al., "Who gets chemotherapy for metastatic lung cancer?", CHEST, 117(5), 2000, pp. 1239-1246
38. Ferrier, CM; Suciu, S; van Geloof, WL; Straatman, H; Eggermont, AMM; Koops, HS; Kroon, BBR; Lejeune, FJ; Kleeberg, UR; van Muijen, GNP; Ruiter, DJ
    High tPA-expression in primary melanoma of the limb correlates with good prognosis
    BRITISH JOURNAL OF CANCER
    
    C.M. Ferrier et al., "High tPA-expression in primary melanoma of the limb correlates with good prognosis", BR J CANC, 83(10), 2000, pp. 1351-1359
39. Kato, T; Kimura, T; Miyakawa, R; Fujii, A; Yamamoto, K; Kameoka, S; Nishikawa, T; Kasajima, T
    Clinicopathologic study associated with long-term survival in Japanese patients with node-negative breast cancer
    BRITISH JOURNAL OF CANCER
    
    T. Kato et al., "Clinicopathologic study associated with long-term survival in Japanese patients with node-negative breast cancer", BR J CANC, 82(2), 2000, pp. 404-411
40. Orr, MS; O'Connor, PM; Kohn, KW
    Effects of c-erbB2 overexpression on the drug sensitivities of normal human mammary epithelial cells
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    M.S. Orr et al., "Effects of c-erbB2 overexpression on the drug sensitivities of normal human mammary epithelial cells", J NAT CANC, 92(12), 2000, pp. 987-994
41. Hoffmann, G; Pollow, K; Weikel, W; Strittmatter, HJ; Bach, J; Schaffrath, M; Knapstein, P; Melchert, F; Pollow, B
    Urokinase and plasminogen activator-inhibitor (PAI-1) status in primary ovarian carcinomas and ovarian metastases compared to benign ovarian tumors as a function of histopathological parameters
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    
    G. Hoffmann et al., "Urokinase and plasminogen activator-inhibitor (PAI-1) status in primary ovarian carcinomas and ovarian metastases compared to benign ovarian tumors as a function of histopathological parameters", CLIN CH L M, 37(1), 1999, pp. 47-54
42. Ross, JS; Fletcher, JA
    The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy
    SEMINARS IN CANCER BIOLOGY
    
    J.S. Ross e J.A. Fletcher, "The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy", SEM CANC B, 9(2), 1999, pp. 125-138
43. Harbeck, N; Ross, JS; Yurdseven, S; Dettmar, P; Polcher, M; Kuhn, W; Ulm, K; Graeff, H; Schmitt, M
    HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    N. Harbeck et al., "HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer", INT J ONCOL, 14(4), 1999, pp. 663-671
44. Baekelandt, M; Holm, R; Trope, CG; Nesland, JM; Kristensen, GB
    The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer
    ANNALS OF ONCOLOGY
    
    M. Baekelandt et al., "The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer", ANN ONCOL, 10(11), 1999, pp. 1335-1341
45. Rungsipipat, A; Tateyama, S; Yamaguchi, R; Uchida, K; Miyoshi, N; Hayashi, T
    Immunohistochemical analysis of c-yes and c-erbB-2 oncogene products and p53 tumor suppressor protein in canine mammary tumors
    JOURNAL OF VETERINARY MEDICAL SCIENCE
    
    A. Rungsipipat et al., "Immunohistochemical analysis of c-yes and c-erbB-2 oncogene products and p53 tumor suppressor protein in canine mammary tumors", J VET MED S, 61(1), 1999, pp. 27-32
46. Jaattela, M
    Heat shock proteins as cellular lifeguards
    ANNALS OF MEDICINE
    
    M. Jaattela, "Heat shock proteins as cellular lifeguards", ANN MED, 31(4), 1999, pp. 261-271
47. Hall, PA; Going, JJ
    Predicting the future: a critical appraisal of cancer prognosis studies
    HISTOPATHOLOGY
    
    P.A. Hall e J.J. Going, "Predicting the future: a critical appraisal of cancer prognosis studies", HISTOPATHOL, 35(6), 1999, pp. 489-494
48. Spath, HM; Carrere, MO; Fervers, B; Philip, T
    Analysis of the eligibility of published economic evaluations for transferto a given health care system - Methodological approach and application tothe French health care system
    HEALTH POLICY
    
    H.M. Spath et al., "Analysis of the eligibility of published economic evaluations for transferto a given health care system - Methodological approach and application tothe French health care system", HEALTH POLI, 49(3), 1999, pp. 161-177
49. Muller-Hocker, J
    Immunoreactivity of p53, Ki-67, and bcl-2 in oncocytic adenomas and carcinomas of the thyroid gland
    HUMAN PATHOLOGY
    
    J. Muller-Hocker, "Immunoreactivity of p53, Ki-67, and bcl-2 in oncocytic adenomas and carcinomas of the thyroid gland", HUMAN PATH, 30(8), 1999, pp. 926-933
50. Wong, SWJ; Rangan, AM; Bilous, AM; Boyages, J; Gebski, V; Benson, EM
    The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting
    PATHOLOGY
    
    S.W.J. Wong et al., "The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting", PATHOLOGY, 31(2), 1999, pp. 90-94
51. Kaufman, CS
    Another view of the Tamoxifen Trial
    JOURNAL OF SURGICAL ONCOLOGY
    
    C.S. Kaufman, "Another view of the Tamoxifen Trial", J SURG ONC, 72(1), 1999, pp. 1-6
52. Duffy, MJ; Maguire, TM; McDermott, EW; O'Higgins, N
    Urokinase plasminogen activator: A prognostic marker in multiple types of cancer
    JOURNAL OF SURGICAL ONCOLOGY
    
    M.J. Duffy et al., "Urokinase plasminogen activator: A prognostic marker in multiple types of cancer", J SURG ONC, 71(2), 1999, pp. 130-135
53. Jaattela, M
    Escaping cell death: Survival proteins in cancer
    EXPERIMENTAL CELL RESEARCH
    
    M. Jaattela, "Escaping cell death: Survival proteins in cancer", EXP CELL RE, 248(1), 1999, pp. 30-43
54. Fukuiwa, T; Takebayashi, Y; Akiba, S; Matsuzaki, T; Hanamure, Y; Miyadera, K; Yamada, Y; Akiyama, S
    Expression of thymidine phosphorylase and vascular endothelial cell growthfactor in human head and neck squamous cell carcinoma and their different characteristics
    CANCER
    
    T. Fukuiwa et al., "Expression of thymidine phosphorylase and vascular endothelial cell growthfactor in human head and neck squamous cell carcinoma and their different characteristics", CANCER, 85(4), 1999, pp. 960-969
55. Huuhtanen, RL; Blomqvist, CP; Wiklund, TA; Bohling, TO; Virolainen, MJ; Tukiainen, EJ; Tribukait, B; Andersson, LC
    Comparison of the Ki-67 score and S-phase fraction as prognostic variablesin soft tissue sarcoma
    BRITISH JOURNAL OF CANCER
    
    R.L. Huuhtanen et al., "Comparison of the Ki-67 score and S-phase fraction as prognostic variablesin soft tissue sarcoma", BR J CANC, 79(5-6), 1999, pp. 945-951
56. Falcon, O; Chirino, R; Leon, L; Lopez-Bonilla, A; Torres, S; Fernandez, L; Garcia-Hernandez, JA; Valeron, PF; Diaz-Chico, JC
    Low levels of cathepsin D are associated with a poor prognosis in endometrial cancer
    BRITISH JOURNAL OF CANCER
    
    O. Falcon et al., "Low levels of cathepsin D are associated with a poor prognosis in endometrial cancer", BR J CANC, 79(3-4), 1999, pp. 570-576
57. Karrison, TG; Ferguson, DJ; Meier, P
    Dormancy of mammary carcinoma after mastectomy
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    T.G. Karrison et al., "Dormancy of mammary carcinoma after mastectomy", J NAT CANC, 91(1), 1999, pp. 80-85
58. STOMPER PC; DEBLOOM JR; LEVINE E; BUDNICK RM; STEWART CC
    FLOW CYTOMETRIC DNA ANALYSIS OF INVASIVE CARCINOMAS DETECTED BY SCREENING MAMMOGRAPHY - USE OF SPECIMEN MAMMOGRAPHY-GUIDED FINE-NEEDLE ASPIRATES
    Clinical cancer research
    
    P.C. Stomper et al., "FLOW CYTOMETRIC DNA ANALYSIS OF INVASIVE CARCINOMAS DETECTED BY SCREENING MAMMOGRAPHY - USE OF SPECIMEN MAMMOGRAPHY-GUIDED FINE-NEEDLE ASPIRATES", Clinical cancer research, 4(7), 1998, pp. 1789-1795
59. LENZ HJ; DANENBERG KD; LEICHMAN CG; FLORENTINE B; JOHNSTON PG; GROSHEN S; ZHOU LY; XIONG YP; DANENBERG PV; LEICHMAN LP
    P53 AND THYMIDYLATE SYNTHASE EXPRESSION IN UNTREATED STAGE-II COLON-CANCER - ASSOCIATIONS WITH RECURRENCE, SURVIVAL, AND SITE
    Clinical cancer research
    
    H.J. Lenz et al., "P53 AND THYMIDYLATE SYNTHASE EXPRESSION IN UNTREATED STAGE-II COLON-CANCER - ASSOCIATIONS WITH RECURRENCE, SURVIVAL, AND SITE", Clinical cancer research, 4(5), 1998, pp. 1227-1234
60. LENZ HJ; DANENBERG KD; LEICHMAN CG; FLORENTINE B; JOHNSTON PG; GROSHEN S; ZHOU LY; XIONG YP; DANENBERG PV; LEICHMAN LP
    P53 AND THYMIDYLATE SYNTHASE EXPRESSION IN UNTREATED STAGE-II COLON-CANCER - ASSOCIATIONS WITH RECURRENCE, SURVIVAL, AND SITE
    Clinical cancer research
    
    H.J. Lenz et al., "P53 AND THYMIDYLATE SYNTHASE EXPRESSION IN UNTREATED STAGE-II COLON-CANCER - ASSOCIATIONS WITH RECURRENCE, SURVIVAL, AND SITE", Clinical cancer research, 4(5), 1998, pp. 1227-1234
61. LENZ HJ; HAYASHI K; SALONGA D; DANENBERG KD; DANENBERG PV; METZGER R; BANERJEE D; BERTINO JR; GROSHEN S; LEICHMAN LP; LEICHMAN CG
    P53 POINT MUTATIONS AND THYMIDYLATE SYNTHASE MESSENGER-RNA LEVELS IN DISSEMINATED COLORECTAL-CANCER - AN ANALYSIS OF RESPONSE AND SURVIVAL
    Clinical cancer research
    
    H.J. Lenz et al., "P53 POINT MUTATIONS AND THYMIDYLATE SYNTHASE MESSENGER-RNA LEVELS IN DISSEMINATED COLORECTAL-CANCER - AN ANALYSIS OF RESPONSE AND SURVIVAL", Clinical cancer research, 4(5), 1998, pp. 1243-1250
62. LENZ HJ; HAYASHI K; SALONGA D; DANENBERG KD; DANENBERG PV; METZGER R; BANERJEE D; BERTINO JR; GROSHEN S; LEICHMAN LP; LEICHMAN CG
    P53 POINT MUTATIONS AND THYMIDYLATE SYNTHASE MESSENGER-RNA LEVELS IN DISSEMINATED COLORECTAL-CANCER - AN ANALYSIS OF RESPONSE AND SURVIVAL
    Clinical cancer research
    
    H.J. Lenz et al., "P53 POINT MUTATIONS AND THYMIDYLATE SYNTHASE MESSENGER-RNA LEVELS IN DISSEMINATED COLORECTAL-CANCER - AN ANALYSIS OF RESPONSE AND SURVIVAL", Clinical cancer research, 4(5), 1998, pp. 1243-1250
63. MA L; RONAI A; RIEDE UN; KOHLER G
    EXPRESSION OF P53 AND BCL-2 IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - AN IMMUNOHISTOCHEMICAL STUDY
    Applied immunohistochemistry
    
    L. Ma et al., "EXPRESSION OF P53 AND BCL-2 IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - AN IMMUNOHISTOCHEMICAL STUDY", Applied immunohistochemistry, 6(2), 1998, pp. 77-83
64. WELLHAUSEN L; SAEGER W; MULLER W; DERWAHL M; HAMACHER C; LUDECKE DK
    GS-ALPHA, PROTEIN-KINASE-C, CATHEPSIN-D, GROWTH-FACTORS, ESTROGEN RECEPTOR-RELATED PROTEIN, AND P53 IN PROLACTIN CELL ADENOMAS AND NULL-CELL ADENOMAS OF THE PITUITARY
    Endocrine pathology
    
    L. Wellhausen et al., "GS-ALPHA, PROTEIN-KINASE-C, CATHEPSIN-D, GROWTH-FACTORS, ESTROGEN RECEPTOR-RELATED PROTEIN, AND P53 IN PROLACTIN CELL ADENOMAS AND NULL-CELL ADENOMAS OF THE PITUITARY", Endocrine pathology, 9(2), 1998, pp. 135-148
65. ELLIS LM; WALKER RA; GASPARINI G
    IS DETERMINATION OF ANGIOGENIC ACTIVITY IN HUMAN TUMORS CLINICALLY USEFUL
    European journal of cancer
    
    L.M. Ellis et al., "IS DETERMINATION OF ANGIOGENIC ACTIVITY IN HUMAN TUMORS CLINICALLY USEFUL", European journal of cancer, 34(5), 1998, pp. 609-618
66. Berger, K; Fischer, T; Szucs, TD
    Cost-effectiveness analysis of paclitaxel acid cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective
    EUROPEAN JOURNAL OF CANCER
    
    K. Berger et al., "Cost-effectiveness analysis of paclitaxel acid cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective", EUR J CANC, 34(12), 1998, pp. 1894-1901
67. BIESTERFELD S; HOFFMANN E
    MIB-1 IMMUNOHISTOMETRY ON TRU-CUT BIOPSIES IN INFLAMMATORY AND CIRRHOTIC LIVER-DISEASE
    Analytical and quantitative cytology and histology
    
    S. Biesterfeld e E. Hoffmann, "MIB-1 IMMUNOHISTOMETRY ON TRU-CUT BIOPSIES IN INFLAMMATORY AND CIRRHOTIC LIVER-DISEASE", Analytical and quantitative cytology and histology, 20(4), 1998, pp. 268-274
68. HALLAK R; LOTTER O; SAFI F; JOUMA M
    EVALUATION OF AN IMMUNOLUMINOMETRIC BASED ASSAY AS A NOVEL METHOD FORTHE QUANTITATIVE-ANALYSIS OF P53 PROTEIN IN TUMOR-TISSUES
    Saudi medical journal
    
    R. Hallak et al., "EVALUATION OF AN IMMUNOLUMINOMETRIC BASED ASSAY AS A NOVEL METHOD FORTHE QUANTITATIVE-ANALYSIS OF P53 PROTEIN IN TUMOR-TISSUES", Saudi medical journal, 19(4), 1998, pp. 483-487
69. TSUDA H; AKIYAMA F; KUROSUMI M; SAKAMOTO G; WATANABE T
    ESTABLISHMENT OF HISTOLOGICAL CRITERIA FOR HIGH-RISK NODE-NEGATIVE BREAST-CARCINOMA FOR A MULTIINSTITUTIONAL RANDOMIZED CLINICAL-TRIAL OF ADJUVANT THERAPY
    Japanese Journal of Clinical Oncology
    
    H. Tsuda et al., "ESTABLISHMENT OF HISTOLOGICAL CRITERIA FOR HIGH-RISK NODE-NEGATIVE BREAST-CARCINOMA FOR A MULTIINSTITUTIONAL RANDOMIZED CLINICAL-TRIAL OF ADJUVANT THERAPY", Japanese Journal of Clinical Oncology, 28(8), 1998, pp. 486-491
70. ARDAVANIS A; SCORILAS A; LOUKERI A; GERAKINI F; PISSAKAS G; MISSITZIS I; APOSTOLIKAS N; YIOTIS I
    CATHEPSIN-D MAY HELP IN DISCRIMINATING NODE-NEGATIVE BREAST-CANCER PATIENTS AT RISK FOR LOCAL-REGIONAL RECURRENCE
    Anticancer research
    
    A. Ardavanis et al., "CATHEPSIN-D MAY HELP IN DISCRIMINATING NODE-NEGATIVE BREAST-CANCER PATIENTS AT RISK FOR LOCAL-REGIONAL RECURRENCE", Anticancer research, 18(4B), 1998, pp. 2885-2890
71. Muller, W; Schneiders, A; Hommel, G; Gabbert, HE
    Prognostic value of bcl-2 expression in gastric cancer
    ANTICANCER RESEARCH
    
    W. Muller et al., "Prognostic value of bcl-2 expression in gastric cancer", ANTICANC R, 18(6B), 1998, pp. 4699-4704
72. HUNG MC; CHANG JYJ; XING XM
    PRECLINICAL AND CLINICAL-STUDY OF HER-2 NEU-TARGETING CANCER GENE-THERAPY/
    Advanced drug delivery reviews
    
    M.C. Hung et al., "PRECLINICAL AND CLINICAL-STUDY OF HER-2 NEU-TARGETING CANCER GENE-THERAPY/", Advanced drug delivery reviews, 30(1-3), 1998, pp. 219-227
73. KOGAN I; BALLINGER JR; REDSHAW R; DIAMANDIS EP; MELEGOS DN; KUBA RM; RAUTH AM
    PROSTATE-SPECIFIC ANTIGEN INDUCTION BY A STEROID-HORMONE IN T47D CELLS GROWING IN SCID MICE
    Breast cancer research and treatment
    
    I. Kogan et al., "PROSTATE-SPECIFIC ANTIGEN INDUCTION BY A STEROID-HORMONE IN T47D CELLS GROWING IN SCID MICE", Breast cancer research and treatment, 48(1), 1998, pp. 73-80
74. Hayes, DF; Trock, B; Harris, AL
    Assessing the clinical impact of prognostic factors: When is "statistically significant" clinically useful?
    BREAST CANCER RESEARCH AND TREATMENT
    
    D.F. Hayes et al., "Assessing the clinical impact of prognostic factors: When is "statistically significant" clinically useful?", BREAST CANC, 52(1-3), 1998, pp. 305-319
75. SCHUSTERMAN MA
    THE FREE TRAM FLAP
    Clinics in plastic surgery
    
    M.A. Schusterman, "THE FREE TRAM FLAP", Clinics in plastic surgery, 25(2), 1998, pp. 191
76. CALDES T; INIESTA P; VEGA FJ; DEJUAN C; LOPEZ JA; DIAZRUBIO E; FERNANDEZ C; CERDAN J; BALIBREA JL; BENITO M
    COMPARATIVE SURVIVAL ANALYSIS OF P53 GENE-MUTATIONS AND PROTEIN ACCUMULATION IN COLORECTAL-CANCER
    Oncology
    
    T. Caldes et al., "COMPARATIVE SURVIVAL ANALYSIS OF P53 GENE-MUTATIONS AND PROTEIN ACCUMULATION IN COLORECTAL-CANCER", Oncology, 55(3), 1998, pp. 249-257
77. WEIDNER N
    TUMORAL VASCULARITY AS A PROGNOSTIC FACTOR IN CANCER-PATIENTS - THE EVIDENCE CONTINUES TO GROW
    Journal of pathology
    
    N. Weidner, "TUMORAL VASCULARITY AS A PROGNOSTIC FACTOR IN CANCER-PATIENTS - THE EVIDENCE CONTINUES TO GROW", Journal of pathology, 184(2), 1998, pp. 119-122
78. ZENILMAN ME
    SURGERY IN THE ELDERLY - IN BRIEF
    Current problems in surgery
    
    M.E. Zenilman, "SURGERY IN THE ELDERLY - IN BRIEF", Current problems in surgery, 35(2), 1998, pp. 104-179
79. GIMENEZ A; MINGUELA A; PARRILLA P; BERMEJO J; PEREZ D; MOLINA J; GARCIA AM; ORTIZ MA; ALVAREZ R; DEHARO LM
    FLOW CYTOMETRIC DNA ANALYSIS AND P53 PROTEIN EXPRESSION SHOW A GOOD CORRELATION WITH HISTOLOGIC-FINDINGS IN PATIENTS WITH BARRETTS-ESOPHAGUS
    Cancer
    
    A. Gimenez et al., "FLOW CYTOMETRIC DNA ANALYSIS AND P53 PROTEIN EXPRESSION SHOW A GOOD CORRELATION WITH HISTOLOGIC-FINDINGS IN PATIENTS WITH BARRETTS-ESOPHAGUS", Cancer, 83(4), 1998, pp. 641-651
80. LEE WJ; SHUN CT; HONG RL; WU MS; CHANG KJ; CHEN KM
    OVEREXPRESSION OF P53 PREDICTS SHORTER SURVIVAL IN DIFFUSE-TYPE GASTRIC-CANCER
    British Journal of Surgery
    
    W.J. Lee et al., "OVEREXPRESSION OF P53 PREDICTS SHORTER SURVIVAL IN DIFFUSE-TYPE GASTRIC-CANCER", British Journal of Surgery, 85(8), 1998, pp. 1138-1142
81. DECENSI A; ROBERTSON C; ROTMENSZ N; SEVERI G; MAISONNEUVE P; SACCHINI V; BOYLE P; COSTA A; VERONESI U
    EFFECTS OF TAMOXIFEN AND TRANSDERMAL HORMONE REPLACEMENT THERAPY ON CARDIOVASCULAR RISK-FACTORS IN A PREVENTION TRIAL
    British Journal of Cancer
    
    A. Decensi et al., "EFFECTS OF TAMOXIFEN AND TRANSDERMAL HORMONE REPLACEMENT THERAPY ON CARDIOVASCULAR RISK-FACTORS IN A PREVENTION TRIAL", British Journal of Cancer, 78(5), 1998, pp. 572-578
82. Ferrandina, G; Scambia, G; Fagotti, A; D'Agostino, G; Panici, PB; Carbone, A; Mancuso, S
    Immunoradiometric and immunohistochemical analysis of cathepsin D in ovarian cancer: lack of association with clinical outcome
    BRITISH JOURNAL OF CANCER
    
    G. Ferrandina et al., "Immunoradiometric and immunohistochemical analysis of cathepsin D in ovarian cancer: lack of association with clinical outcome", BR J CANC, 78(12), 1998, pp. 1645-1652
83. GORIN MB; DAY R; COSTANTINO JP; FISHER B; REDMOND CK; WICKERHAM L; GOMOLIN JES; MARGOLESE RG; MATHEN MK; BOWMAN DM; KAUFMANN D; DIMITROV NV; SINGERMAN LJ; BORNSTEIN R; WOLMARK N
    LONG-TERM TAMOXIFEN CITRATE USE AND POTENTIAL OCULAR TOXICITY
    American journal of ophthalmology
    
    M.B. Gorin et al., "LONG-TERM TAMOXIFEN CITRATE USE AND POTENTIAL OCULAR TOXICITY", American journal of ophthalmology, 125(4), 1998, pp. 493-501
84. VENERONI S; SILVESTRINI R; COSTA A; SALVATORI P; FARANDA A; MOLINARI R
    BIOLOGICAL INDICATORS OF SURVIVAL IN PATIENTS TREATED BY SURGERY FOR SQUAMOUS-CELL CARCINOMA OF THE ORAL CAVITY AND OROPHARYNX
    Oral Oncology
    
    S. Veneroni et al., "BIOLOGICAL INDICATORS OF SURVIVAL IN PATIENTS TREATED BY SURGERY FOR SQUAMOUS-CELL CARCINOMA OF THE ORAL CAVITY AND OROPHARYNX", Oral Oncology, 33(6), 1997, pp. 408-413
85. PANDELIDIS SM; PETERS KL; WALUSIMBI MS; CASADY RL; LAUX SV; CAVANAUGH SH; BAUER TL
    THE ROLE OF AXILLARY DISSECTION IN MAMMOGRAPHICALLY DETECTED CARCINOMA
    Journal of the American College of Surgeons
    
    S.M. Pandelidis et al., "THE ROLE OF AXILLARY DISSECTION IN MAMMOGRAPHICALLY DETECTED CARCINOMA", Journal of the American College of Surgeons, 184(4), 1997, pp. 341-345
86. NAGUIB RNG; SHERBET GV
    ARTIFICIAL NEURAL NETWORKS IN CANCER-RESEARCH
    Pathobiology
    
    R.N.G. Naguib e G.V. Sherbet, "ARTIFICIAL NEURAL NETWORKS IN CANCER-RESEARCH", Pathobiology, 65(3), 1997, pp. 129-139
87. FARANDA A; COSTA A; CANOVA S; ABOLAFIO G; SILVESTRINI R
    IMAGE AND FLOW CYTOMETRIC ANALYSES OF DNA CONTENT IN HUMAN SOLID TUMORS - A COMPARATIVE-STUDY
    Analytical and quantitative cytology and histology
    
    A. Faranda et al., "IMAGE AND FLOW CYTOMETRIC ANALYSES OF DNA CONTENT IN HUMAN SOLID TUMORS - A COMPARATIVE-STUDY", Analytical and quantitative cytology and histology, 19(4), 1997, pp. 338-344
88. COSTA A; DOCI R; MOCHEN C; BIGNAMI P; FARANDA A; GENNARI L; SILVESTRINI R
    CELL PROLIFERATION-RELATED MARKERS IN COLORECTAL LIVER METASTASES - CORRELATION WITH PATIENT PROGNOSIS
    Journal of clinical oncology
    
    A. Costa et al., "CELL PROLIFERATION-RELATED MARKERS IN COLORECTAL LIVER METASTASES - CORRELATION WITH PATIENT PROGNOSIS", Journal of clinical oncology, 15(5), 1997, pp. 2008-2014
89. RAYBAUDDIOGENE H; FORTIN A; MORENCY R; ROY J; MONTEIL RA; TETU B
    MARKERS OF RADIORESISTANCE IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK - A CLINICOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY
    Journal of clinical oncology
    
    H. Raybauddiogene et al., "MARKERS OF RADIORESISTANCE IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK - A CLINICOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY", Journal of clinical oncology, 15(3), 1997, pp. 1030-1038
90. IWAYA K; TSUDA H; FUKUTOMI T; TSUGANE S; SUZUKI M; HIROHASHI S
    HISTOLOGIC GRADE AND P53 IMMUNOREACTION AS INDICATORS OF EARLY RECURRENCE OF NODE-NEGATIVE BREAST-CANCER
    Japanese Journal of Clinical Oncology
    
    K. Iwaya et al., "HISTOLOGIC GRADE AND P53 IMMUNOREACTION AS INDICATORS OF EARLY RECURRENCE OF NODE-NEGATIVE BREAST-CANCER", Japanese Journal of Clinical Oncology, 27(1), 1997, pp. 6-12
91. DEMETS DL
    DISTINCTIONS BETWEEN FRAUD, BIAS, ERRORS, MISUNDERSTANDING, AND INCOMPETENCE
    Controlled clinical trials
    
    D.L. Demets, "DISTINCTIONS BETWEEN FRAUD, BIAS, ERRORS, MISUNDERSTANDING, AND INCOMPETENCE", Controlled clinical trials, 18(6), 1997, pp. 637-650
92. VERMEULEN PB; LIBURA M; LIBURA J; ONEILL PJ; VANDAM P; VANMARCK E; VANOOSTEROM AT; DIRIX LY
    INFLUENCE OF INVESTIGATOR EXPERIENCE AND MICROSCOPIC FIELD SIZE ON MICROVESSEL DENSITY IN NODE-NEGATIVE BREAST-CARCINOMA
    Breast cancer research and treatment
    
    P.B. Vermeulen et al., "INFLUENCE OF INVESTIGATOR EXPERIENCE AND MICROSCOPIC FIELD SIZE ON MICROVESSEL DENSITY IN NODE-NEGATIVE BREAST-CARCINOMA", Breast cancer research and treatment, 42(2), 1997, pp. 165-172
93. MELTZER D
    ACCOUNTING FOR FUTURE COSTS IN MEDICAL COST-EFFECTIVENESS ANALYSIS
    Journal of health economics
    
    D. Meltzer, "ACCOUNTING FOR FUTURE COSTS IN MEDICAL COST-EFFECTIVENESS ANALYSIS", Journal of health economics, 16(1), 1997, pp. 33-64
94. MULLERHOCKER J; OBERNITZ N; JOHANNES A; LOHRS U
    P53 GENE-PRODUCT AND EGF-RECEPTOR ARE HIGHLY EXPRESSED IN PLACENTAL SITE TROPHOBLASTIC TUMOR
    Human pathology
    
    J. Mullerhocker et al., "P53 GENE-PRODUCT AND EGF-RECEPTOR ARE HIGHLY EXPRESSED IN PLACENTAL SITE TROPHOBLASTIC TUMOR", Human pathology, 28(11), 1997, pp. 1302-1306
95. DIAMANDIS EP
    CLINICAL-APPLICATIONS OF TUMOR-SUPPRESSOR GENES AND ONCOGENES IN CANCER
    Clinica chimica acta
    
    E.P. Diamandis, "CLINICAL-APPLICATIONS OF TUMOR-SUPPRESSOR GENES AND ONCOGENES IN CANCER", Clinica chimica acta, 257(2), 1997, pp. 157-180
96. LONARDO F; UEDA T; HUVOS AG; HEALY J; LADANYI M
    P53 AND MDM2 ALTERATIONS IN OSTEOSARCOMAS - CORRELATION WITH CLINICOPATHOLOGICAL FEATURES AND PROLIFERATIVE RATE
    Cancer
    
    F. Lonardo et al., "P53 AND MDM2 ALTERATIONS IN OSTEOSARCOMAS - CORRELATION WITH CLINICOPATHOLOGICAL FEATURES AND PROLIFERATIVE RATE", Cancer, 79(8), 1997, pp. 1541-1547
97. DETTMAR P; HARBECK N; THOMSSEN C; PACHE L; ZIFFER P; FIZI K; JANICKE F; NATHRATH W; SCHMITT M; GRAEFF H; HOFLER H
    PROGNOSTIC IMPACT OF PROLIFERATION-ASSOCIATED FACTORS MIBI (KI-67) AND S-PHASE IN NODE-NEGATIVE BREAST-CANCER
    British Journal of Cancer
    
    P. Dettmar et al., "PROGNOSTIC IMPACT OF PROLIFERATION-ASSOCIATED FACTORS MIBI (KI-67) AND S-PHASE IN NODE-NEGATIVE BREAST-CANCER", British Journal of Cancer, 75(10), 1997, pp. 1525-1533
98. BLAND KI
    ADVANCES IN MOLECULAR-GENETICS
    The American journal of surgery
    
    K.I. Bland, "ADVANCES IN MOLECULAR-GENETICS", The American journal of surgery, 173(1), 1997, pp. 42-43
99. CHAN HSL; LING V
    ANTI-P-GLYCOPROTEIN ANTIBODY C219 CROSS-REACTIVITY WITH C-ERBB2 PROTEIN - DIAGNOSTIC AND CLINICAL IMPLICATIONS
    Journal of the National Cancer Institute
    
    H.S.L. Chan e V. Ling, "ANTI-P-GLYCOPROTEIN ANTIBODY C219 CROSS-REACTIVITY WITH C-ERBB2 PROTEIN - DIAGNOSTIC AND CLINICAL IMPLICATIONS", Journal of the National Cancer Institute, 89(20), 1997, pp. 1473-1476
100. COSTANTINO JP; KULLER LH; IVES DG; FISHER B; DIGNAM J
     CORONARY HEART-DISEASE MORTALITY AND ADJUVANT TAMOXIFEN THERAPY
     Journal of the National Cancer Institute
     
     J.P. Costantino et al., "CORONARY HEART-DISEASE MORTALITY AND ADJUVANT TAMOXIFEN THERAPY", Journal of the National Cancer Institute, 89(11), 1997, pp. 776-782